Dr. Nandita Singh, D.O

NPI: 1912108937
Total Payments
$500.00
2024 Payments
$21.43
Companies
5
Transactions
18
Medicare Patients
1,189
Medicare Billing
$389,740

Payment Breakdown by Category

Food & Beverage$500.00 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $500.00 18 100.0%

Top Paying Companies

Company Total Records Latest Year
Alexion Pharmaceuticals, Inc. $240.19 2 $0 (2019)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $204.70 13 $0 (2024)
Melinta Therapeutics, LLC $22.14 1 $0 (2023)
Paratek Pharmaceuticals, Inc. $19.84 1 $0 (2022)
Alnylam Pharmaceuticals Inc. $13.13 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $21.43 1 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($21.43)
2023 $22.14 1 Melinta Therapeutics, LLC ($22.14)
2022 $182.11 12 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($149.14)
2021 $34.13 2 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($34.13)
2019 $121.77 1 Alexion Pharmaceuticals, Inc. ($121.77)
2018 $118.42 1 Alexion Pharmaceuticals, Inc. ($118.42)

All Payment Transactions

18 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/18/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $21.43 General
Category: Gastroenterology
10/06/2023 Melinta Therapeutics, LLC Rezzayo (Drug), Kimyrsa, Vabomere Food and Beverage In-kind items and services $22.14 General
Category: ANTIFUNGALS
12/01/2022 Alnylam Pharmaceuticals Inc. GIVLAARI (Drug) Food and Beverage In-kind items and services $13.13 General
Category: Genetic Disease
11/30/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $23.00 General
Category: Gastroenterology
11/18/2022 Paratek Pharmaceuticals, Inc. NUZYRA (Drug) Food and Beverage In-kind items and services $19.84 General
Category: ANTIBIOTIC
11/16/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $16.55 General
Category: Gastroenterology
06/22/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $9.58 General
Category: Gastroenterology
05/25/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $9.79 General
Category: Gastroenterology
05/25/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $3.78 General
Category: Gastroenterology
04/27/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $17.28 General
Category: Gastroenterology
03/30/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $23.33 General
Category: Gastroenterology
03/23/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $17.48 General
Category: Gastroenterology
03/16/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.18 General
Category: Gastroenterology
02/01/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.17 General
Category: Gastroenterology
12/20/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $12.76 General
Category: Gastroenterology
12/15/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $21.37 General
Category: Gastroenterology
06/27/2019 Alexion Pharmaceuticals, Inc. SOLIRIS (Drug) Food and Beverage In-kind items and services $121.77 General
Category: Immunology
02/27/2018 Alexion Pharmaceuticals, Inc. SOLIRIS (Drug) Food and Beverage In-kind items and services $118.42 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 247 687 $333,474 $91,304
2022 6 338 994 $467,050 $125,035
2021 5 309 894 $380,045 $101,524
2020 7 295 817 $285,994 $71,876
Total Patients
1,189
Total Services
3,392
Medicare Billing
$389,740
Procedure Codes
21

All Medicare Procedures & Services

21 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 160 296 $166,944 $46,725 28.0%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 59 361 $143,317 $39,955 27.9%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 28 30 $23,213 $4,625 19.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 158 310 $174,840 $53,162 30.4%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 70 533 $211,601 $51,584 24.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 50 89 $37,469 $9,429 25.2%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 24 24 $19,484 $5,184 26.6%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 22 24 $12,792 $3,058 23.9%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 14 14 $10,864 $2,619 24.1%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 58 411 $163,167 $40,116 24.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 114 273 $114,933 $33,162 28.9%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 80 109 $61,476 $18,565 30.2%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 39 49 $26,117 $6,199 23.7%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 18 52 $14,352 $3,483 24.3%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 57 373 $99,384 $24,587 24.7%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 106 207 $83,573 $20,122 24.1%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 34 126 $48,747 $11,976 24.6%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 36 46 $23,770 $5,924 24.9%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 28 29 $15,573 $4,063 26.1%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 15 16 $12,000 $3,099 25.8%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2020 19 20 $2,947 $2,105 71.4%

About Dr. Nandita Singh, D.O

Dr. Nandita Singh, D.O is a Internal Medicine healthcare provider based in Valhalla, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1912108937.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nandita Singh, D.O has received a total of $500.00 in payments from pharmaceutical and medical device companies, with $21.43 received in 2024. These payments were reported across 18 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($500.00).

As a Medicare-enrolled provider, Singh has provided services to 1,189 Medicare beneficiaries, totaling 3,392 services with total Medicare billing of $389,740. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Nephrology
  • Location Valhalla, NY
  • Active Since 05/29/2007
  • Last Updated 02/22/2021
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1912108937

Products in Payments

  • SOLIRIS (Drug) $240.19
  • XIFAXAN (Drug) $204.70
  • Rezzayo (Drug) $22.14
  • NUZYRA (Drug) $19.84
  • GIVLAARI (Drug) $13.13

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Valhalla